Claims for Patent: 3,674,836
✉ Email this page to a colleague
Summary for Patent: 3,674,836
| Title: | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
| Abstract: | A series of 2,2-dimethyl- omega -phenoxyalkanoic acids and 2,2dimethyl- omega -(disubstituted phenoxy)alkanoic acids having 3 to 6 methylene groups between the phenoxy group or 0 phenoxy group and the carbon atom substituted by two methyl groups; and their salts and esters. The compounds reduce serum triglyceride levels and can be produced by (a) reacting an alkali metal derivative of an isobutyric acid, salt, or ester with a phenoxyalkyl halide or a disubstituted phenoxyalkyl halide; (b) esterifying a carboxylic acid; or (c) hydrolyzing a carboxylate ester. |
| Inventor(s): | Paul L Creger |
| Assignee: | Parke Davis and Co LLC |
| Application Number: | US819126A |
| Patent Claims: |
2. A compound according to claim 1 wherein R represents hydrogen. 3. A compound according to claim 1 wherein R represents lower alkyl. 4. A compound according to claim 1 which is 2,2-dimethyl-5-phenoxyvaleric acid. 5. A compound according to claim 1 which is 2,2-dimethyl-6-phenoxyhexanoic acid. 6. A compound according to claim 1 which is 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid. 7. A compound according to claim 1 which is 2,2-dimethyl-5-(3,5-xylyloxy)valeric acid. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch